These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26820654)

  • 1. Infection Prevention in Transplantation.
    Pergam SA
    Curr Infect Dis Rep; 2016 Jan; 18(2):7. PubMed ID: 26820654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and Treatment of Clostridium difficile-Associated Diarrhea in Solid Organ Transplant Recipients.
    Pouch SM; Friedman-Moraco RJ
    Infect Dis Clin North Am; 2018 Sep; 32(3):733-748. PubMed ID: 30146033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in solid organ transplant recipients.
    Nanayakkara D; Nanda N
    Curr Opin Organ Transplant; 2017 Aug; 22(4):314-319. PubMed ID: 28542111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile in transplant patients: early diagnosis, treatment, and prevention.
    Revolinski SL; Munoz-Price LS
    Curr Opin Infect Dis; 2019 Aug; 32(4):307-313. PubMed ID: 31116134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection control experience in a cooperative care center for transplant patients.
    Nusair A; Jourdan D; Medcalf S; Marion N; Iwen PC; Fey PD; Reed E; Langnas A; Rupp ME
    Infect Control Hosp Epidemiol; 2008 May; 29(5):424-9. PubMed ID: 18419364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients.
    Kim YJ; Kim SI; Choi JY; Yoon SK; You YK; Kim DG
    Korean J Intern Med; 2015 Sep; 30(5):694-704. PubMed ID: 26354064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal infections after transplantation.
    Danziger-Isakov L
    Curr Opin Gastroenterol; 2014 Jan; 30(1):40-6. PubMed ID: 24257036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection in solid organ transplant recipients.
    Honda H; Dubberke ER
    Curr Opin Infect Dis; 2014 Aug; 27(4):336-41. PubMed ID: 24927151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.
    Rittà M; Costa C; Solidoro P; Sidoti F; Libertucci D; Boffini M; Rinaldi M; Baldi S; Cavallo R
    Antiviral Res; 2015 Jan; 113():19-26. PubMed ID: 25446337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.
    Revolinski SL; Munoz-Price LS
    Clin Infect Dis; 2019 May; 68(12):2144-2153. PubMed ID: 30281082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
    Patterson JE; Peters J; Calhoon JH; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson TF; Rech M; Jorgensen JH; Rinaldi MG; Sako E; Johnson S; Speeg V; Halff GA; Trinkle JK
    Transpl Infect Dis; 2000 Mar; 2(1):22-8. PubMed ID: 11429006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study.
    Schuster MG; Cleveland AA; Dubberke ER; Kauffman CA; Avery RK; Husain S; Paterson DL; Silveira FP; Chiller TM; Benedict K; Murphy K; Pappas PG
    Open Forum Infect Dis; 2017; 4(2):ofx050. PubMed ID: 28491889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prophylaxis regimens following transplantation.
    Subramanian AK
    Curr Opin Infect Dis; 2011 Aug; 24(4):344-9. PubMed ID: 21673573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of infections in solid organ transplant recipients.
    Villacian JS; Paya CV
    Transpl Infect Dis; 1999 Mar; 1(1):50-64. PubMed ID: 11428971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
    Satlin MJ; Walsh TJ
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial.
    El-Khoury J; Fishman JA
    Transpl Infect Dis; 2003 Sep; 5(3):121-5. PubMed ID: 14617299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.
    Razonable RR
    Am J Health Syst Pharm; 2005 Apr; 62(8 Suppl 1):S7-13. PubMed ID: 15821266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.